KATHLEEN VASQUEZ: Open Payments
NPI 1558822791 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 54 payments from 23 companies in 2025. Trend: 2023 $591 · 2024 $1,742 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $210 |
| Janssen Scientific Affairs, LLC | 1 | $132 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| Janssen Biotech, Inc. | 5 | $100 |
| UROGEN PHARMA, INC. | 2 | $52 |
| Endo USA, Inc. | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 6 | $46 |
| Lilly USA, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| TOLMAR, INC. | 2 | $31 |
Products named: TREMFYA, RINVOQ, DUPIXENT, XIAFLEX, ERLEADA, VOQUEZNA, OMVOH, JATENZO.
Industry payments across AR — which companies pay providers there.
